2026 Carter Immunology Center Symposium: Microbiome in Health and Disease

We are excited to announce the upcoming 2026 Carter Immunology Center Symposium: Microbiome in Health and Disease. The human microbiome plays a central role in immune development, tissue homeostasis, and disease pathogenesis, influencing conditions that range from inflammatory and autoimmune disorders to cancer. Rapid advances over the past decade have revealed that microbes—including bacteria, fungi, and viruses—actively shape immune responses at barrier sites and systemically, yet the mechanisms governing these host–microbe interactions remain incompletely understood.

The Carter Immunology Center Symposium speakers are leaders in immunology and microbiome research who will highlight recent discoveries defining how microbial communities regulate immune function with a focus on microbial control of immune development, regulation of intestinal and systemic inflammation, host adaptation to commensal organisms, and emerging therapeutic opportunities targeting host–microbiome interactions. Join us for an opportunity to learn from these distinguished researchers and engage in insightful discussions.

Keynote Speakers:

Daniel Mucida, PhD: Rockefeller University & Howard Hughes Medical Institute
Title: “Neuro-immune-epithelial interactions in type-2 immunity”

Iliyan Iliev, PhD: Weill Cornell Medicine
Title: “Immunity and inflammation through the lens of the gut mycobiota”

Lora Hooper, PhD: University of Texas Southwestern Medical Center
Title: “How the microbiome harnesses vitamin A to shape gut immunity”

Dan Littman, MD, PhD: NYU Grossman School of Medicine
Title: “Regulation of intestinal T cell homeostasis by antigen presenting cells”

Filed Under: Events